![Min-Chul Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Min-Chul Park
Direktor/Vorstandsmitglied bei
ZyVersa Therapeutics Operating, Inc.
Vermögen: - $ am 30.06.2026
Profil
Min-Chul Park is the founder of Tme Therapeutics, Inc. Current jobs include Director at ZyVersa Therapeutics Operating, Inc. and Assistant Professor at Inje University.
Former jobs include Chief Executive Officer & Director at Neomics Co., Ltd., Chief Executive Officer & Director at Curebio Therapeutics in 2022, Chief Executive Officer & Director at CURE BIO Co., Ltd. from 2020 to 2022, Independent Director at ZyVersa Therapeutics, Inc. from 2022 to 2026, and Senior Associate-Research at Medicinal Bioconvergence Research Center.
Education includes a doctorate from Seoul National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.07.2025 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Min-Chul Park
| Unternehmen | Position | Beginn |
|---|---|---|
ZyVersa Therapeutics Operating, Inc.
 ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktor/Vorstandsmitglied | - |
Inje University
 Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Min-Chul Park
| Unternehmen | Position | Ende |
|---|---|---|
| ZYVERSA THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 08.07.2026 |
CURE BIO Co., Ltd.
 CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Vorstandsvorsitzender | 01.04.2022 |
Neomics Co., Ltd.
 Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Vorstandsvorsitzender | 01.01.2017 |
Medicinal Bioconvergence Research Center | Corporate Officer/Principal | - |
Ausbildung von Min-Chul Park
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
6
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
ZyVersa Therapeutics Operating, Inc.
ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neomics Co., Ltd.
Neomics Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes diagnostics and therapeutics for human incurable diseases, such as cancer | Health Technology |
Inje University
Inje University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CURE BIO Co., Ltd.
CURE BIO Co., Ltd. BiotechnologyHealth Technology Engages in research and development of medicines | Health Technology |
ZyVersa Therapeutics, Inc.
 ZyVersa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops product candidates in the areas of renal and inflammatory diseases | Health Technology |
Medicinal Bioconvergence Research Center |
Wählen Sie MarketScreener 
